Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibacterial prophylaxis.

M Cruciani1

  • 1Department of Infectious Diseases, University of Verona, Ospedale Civile Maggiore, P.le Stefani, 1-37126 Verona, Italy. maow@virgilio.it

International Journal of Antimicrobial Agents
|October 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality from COVID-19.

Annali di igiene : medicina preventiva e di comunita·2021
Same author

Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2021
Same author

The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.

The Journal of antimicrobial chemotherapy·2020
Same author

Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group.

Medical mycology·2020
Same author

Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: reply.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same journal

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same journal

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same journal

Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.

International journal of antimicrobial agents·2026
Same journal

Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

International journal of antimicrobial agents·2026
Same journal

In reply to the Letter to Editor regarding "Comment on "Development and validation of a predictive model for profiling antibiotic resistance phenotypes of Acinetobacter baumannii strains via clinical MALDI-TOF mass spectra: A multicenter study".

International journal of antimicrobial agents·2026
Same journal

Comment on "Targeting the human protein disulfide isomerase A3 as a broad-spectrum antiviral approach against human respiratory viruses".

International journal of antimicrobial agents·2026
See all related articles

Neutropenic patients face high risks from bacterial infections. This review emphasizes prophylactic antibacterial agents as a key strategy to reduce infection risk and improve outcomes in these vulnerable individuals.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Clinical Pharmacology

Background:

  • Bacterial infections are a major cause of illness and death in neutropenic patients.
  • Prophylactic strategies aim to minimize infection risk during severe neutropenia.
  • Many traditional methods have lost favor due to limited long-term effectiveness.

Purpose of the Study:

  • To review available prophylactic strategies for neutropenic patients.
  • To focus on the efficacy and application of prophylactic antibacterial agents.

Main Methods:

  • Literature review of prophylactic strategies for neutropenic patients.
  • Emphasis on studies evaluating antibacterial agents.

Main Results:

Related Experiment Videos

  • Various prophylactic measures have been explored, including isolation and transfusions.
  • Concerns regarding long-term efficacy have impacted the adoption of several strategies.
  • Prophylactic antibacterial agents are a significant focus in current management.

    • Conclusions:

    • Prophylactic antibacterial agents are a critical component of infection control in neutropenic patients.
    • Careful consideration of efficacy and patient factors is essential when selecting prophylactic strategies.